107 related articles for article (PubMed ID: 28499311)
1. Evaluation of Bone Mineral Density in Children with Type I Diabetes Mellitus and Relationship to Serum Levels of Osteopontin.
Saki F; Sheikhi A; Omrani GHR; Karimi H; Dabbaghmanesh MH; Mousavinasab SN
Drug Res (Stuttg); 2017 Sep; 67(9):527-533. PubMed ID: 28499311
[TBL] [Abstract][Full Text] [Related]
2. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
3. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women.
Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L
J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile.
Barchetta I; Alessandri C; Bertoccini L; Cimini FA; Taverniti L; Di Franco M; Fraioli A; Baroni MG; Cavallo MG
Eur J Endocrinol; 2016 Feb; 174(2):187-92. PubMed ID: 26578639
[TBL] [Abstract][Full Text] [Related]
5. Increased serum osteopontin is a risk factor for osteoporosis in menopausal women.
Chang IC; Chiang TI; Yeh KT; Lee H; Cheng YW
Osteoporos Int; 2010 Aug; 21(8):1401-9. PubMed ID: 20238102
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
Osteoporos Int; 2017 Mar; 28(3):945-953. PubMed ID: 27766367
[TBL] [Abstract][Full Text] [Related]
7. High serum osteopontin levels are associated with low bone mineral density in postmenopausal women.
Cho EH; Cho KH; Lee HA; Kim SW
J Korean Med Sci; 2013 Oct; 28(10):1496-9. PubMed ID: 24133355
[TBL] [Abstract][Full Text] [Related]
8. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
[TBL] [Abstract][Full Text] [Related]
9. Effect of gender, diabetes duration, inflammatory cytokines, and vitamin D level on bone mineral density among Thai children and adolescents with type 1 diabetes.
Santiprabhob J; Charoentawornpanich P; Khemaprasit K; Manpayak T; Kiattisakthavee P; Pipatsathian A; Wannasilp N; Tangjittipokin W
Bone; 2021 Dec; 153():116112. PubMed ID: 34252600
[TBL] [Abstract][Full Text] [Related]
10. Different health behaviours and clinical factors associated with bone mineral density and bone turnover in premenopausal women with and without type 1 diabetes.
Kujath AS; Quinn L; Elliott ME; LeCaire TJ; Binkley N; Molino AR; Danielson KK
Diabetes Metab Res Rev; 2015 May; 31(4):421-32. PubMed ID: 25470722
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density of both genders in Type 1 diabetes according to bone composition.
Hadjidakis DJ; Raptis AE; Sfakianakis M; Mylonakis A; Raptis SA
J Diabetes Complications; 2006; 20(5):302-7. PubMed ID: 16949517
[TBL] [Abstract][Full Text] [Related]
12. Investigation of osteopontin levels and genomic variation of osteopontin and its receptors in Type 1 diabetes mellitus.
Karamizadeh Z; Kamali Sarvestani E; Saki F; Karamifar H; Amirhakimi GH; Namavar Shooshtarian MH; Ashkani-Esfahani S
J Endocrinol Invest; 2013 Dec; 36(11):1090-3. PubMed ID: 24084141
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin regulates anabolic effect in human menopausal osteoporosis with intermittent parathyroid hormone treatment.
Chiang TI; Chang IC; Lee HS; Lee H; Huang CH; Cheng YW
Osteoporos Int; 2011 Feb; 22(2):577-85. PubMed ID: 20734029
[TBL] [Abstract][Full Text] [Related]
14. Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients.
Abd El Dayem SM; El-Shehaby AM; Abd El Gafar A; Fawzy A; Salama H
Scand J Clin Lab Invest; 2011 Sep; 71(5):387-93. PubMed ID: 21476826
[TBL] [Abstract][Full Text] [Related]
15. Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies.
Pan H; Wu N; Yang T; He W
Diabetes Metab Res Rev; 2014 Oct; 30(7):531-42. PubMed ID: 24376190
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: relationship to microvascular complications and bone mineral density.
AboElAsrar MA; Elbarbary NS; Elshennawy DE; Omar AM
Cytokine; 2012 Jul; 59(1):86-93. PubMed ID: 22513191
[TBL] [Abstract][Full Text] [Related]
17. The Role of Osteopontin in the Pathogenesis and Complications of Type 1 Diabetes Mellitus in Children.
Talat MA; Sherief LM; El-Saadany HF; Rass AA; Saleh RM; Sakr MM
J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):399-404. PubMed ID: 27353561
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin in bone mineral density of very old Brazilians.
Souza VC; Freitas WM; Quaglia LA; Santos SN; Córdova C; Sposito AC; Nóbrega OT
J Bone Miner Metab; 2013 Jul; 31(4):449-54. PubMed ID: 23515922
[TBL] [Abstract][Full Text] [Related]
19. Decreased bone mineral density in Costello syndrome.
Leoni C; Stevenson DA; Martini L; De Sanctis R; Mascolo G; Pantaleoni F; De Santis S; La Torraca I; Persichilli S; Caradonna P; Tartaglia M; Zampino G
Mol Genet Metab; 2014 Jan; 111(1):41-5. PubMed ID: 24246682
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
Abeş M; Sarihan H; Madenci E
J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
